Skip to main content

Table 1 Baseline characteristics of enrolled patients /lesions1

From: Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: a pilot study

Patient No.

No. lesions

Age (years)

Etiology

Child–Pugh grade

ALBI grade

BCLC stage

AFP (ng/ml)

ALB (g/dL)

1

2

60s

HCV

A6

2

B1

153

3.3

2

2

80s

HCV

A6

2

A4

56

3.2

3

2

60s

HCV

A5

1

B1

581

4.6

4

5

60s

HCV

A5

1

B1

2

4.1

5

2

60s

HCV

A5

2

A4

9

4.0

6

3

80s

Alc

A5

1

B1

62

4.6

7

2

60s

HCV

A6

2

A4

144

3.4

8

4

70s

HCV

A5

2

B1

11

3.5

9

4

70s

NBNC

A5

1

B1

4

4.3

10

2

80s

HCV

A5

2

A4

9

3.9

11

2

70s

HCV

A5

1

A4

7

4.7

12

2

80s

HCV

A6

1

B1

66

4.4

13

2

80s

HCV

B7

1

A4

12

4.7

14

3

80s

NBNC

A5

2

A4

4

4.0

15

2

60s

HCV

A5

1

A4

2

4.9

Total2

2.7 (2–5)

73 (63–86)

12/2/1

9/4/1

8/7

8/7

73.2 (2–581)

4.1 (3.2–4.7)

  1. 1 HCC: Hepatocellular carcinoma; HCV: hepatitis C virus; HBV: hepatitis B virus; NBNC: non-HBV non-HCV; Alc: Alcohol abuse; BCLC: Barcelona Clinic Liver Cancer; ALBI:albumin–bilirubin; AFP: alpha-fetoprotein; ALB: Albumin; M:male; F:female
  2. 2 In this line, the order for etiology is HCV, NBNC, and Alc; for Child–Pugh grade, the order is A5, A6, and B8; while for BCLC stage, it is A4 and B1